Picture of Vicore Pharma Holding AB logo

VICO — Vicore Pharma Holding AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Vicore Confirms IPF Development Program On Track, Provides Updates

Jan 2 (Reuters) - Vicore Pharma Holding AB  VICOR.ST :
    * VICORE CONFIRMS IPF DEVELOPMENT PROGRAM ON TRACK AND
PROVIDES
EARLY-STAGE PIPELINE UPDATES
    * TOPLINE RESULTS FROM ALMEETM PIVOTAL STUDY COMPANION
EXPECTED TO
BE ANNOUNCED THIS MONTH
    * CONTINUES TO FOCUS ON DEVELOPMENT OF C21 FOR IDIOPATHIC
PULMONARY FIBROSIS (IPF)

Source text for Eikon:  ID:nMFN8cnf1g 
Further company coverage:  VICOR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Vicore Pharma Holding AB

See all news